PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Felix L. Herr; Christian Dascalescu; Matthias P. Fabritius; Gabriel T. Sheikh; Mathias J. Zacherl; Vera Wenter; Lena M. Unterrainer; Matthias Brendel; Adrien Holzgreve; Christoph J. Auernhammer; Christine Spitzweg; Tanja Burkard; Jens Ricke; Maurice M. Heimer; Clemens C. Cyran

doi:10.2967/jnumed.124.268621

Research ArticleClinical Investigation

PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Felix L. Herr, Christian Dascalescu, Matthias P. Fabritius, Gabriel T. Sheikh, Mathias J. Zacherl, Vera Wenter, Lena M. Unterrainer, Matthias Brendel, Adrien Holzgreve, Christoph J. Auernhammer, Christine Spitzweg, Tanja Burkard, Jens Ricke, Maurice M. Heimer and Clemens C. Cyran

Journal of Nuclear Medicine May 2025, 66 (5) 726-731; DOI: https://doi.org/10.2967/jnumed.124.268621

Felix L. Herr

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christian Dascalescu

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias P. Fabritius

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gabriel T. Sheikh

2Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mathias J. Zacherl

2Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vera Wenter

2Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Lena M. Unterrainer

2Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany;

3Bayerisches Zentrum für Krebsforschung, partner site Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Matthias Brendel

2Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany;

4German Center for Neurodegenerative Diseases, Munich, Germany;

5Munich Cluster for Systems Neurology (SyNergy), University of Munich, Munich, Germany;

6German Cancer Consortium, partner site Munich, a partnership between DKFZ and LMU, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Adrien Holzgreve

2Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christoph J. Auernhammer

7Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany; and

8Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Christine Spitzweg

7Interdisciplinary Center of Neuroendocrine Tumors of the GastroEnteroPancreatic System (GEPNET-KUM, ENETS certified Center of Excellence), LMU University Hospital, LMU Munich, Munich, Germany; and

8Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Tanja Burkard

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jens Ricke

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Maurice M. Heimer

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Clemens C. Cyran

1Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 66, Issue 5

May 1, 2025

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author
Complete Issue (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Journal of Nuclear Medicine May 2025, 66 (5) 726-731; DOI: 10.2967/jnumed.124.268621

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Journal of Nuclear Medicine May 2025, 66 (5) 726-731; DOI: 10.2967/jnumed.124.268621

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Keywords

GEP-NET
SSTR PET/CT
RPT
response criteria
human studies

Main menu

User menu

Search

PET- and CT-Based Imaging Criteria for Response Assessment of Gastroenteropancreatic Neuroendocrine Tumors Under Radiopharmaceutical Therapy

Individuals

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords